Your browser doesn't support javascript.
loading
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
Bazinet, Alexandre; Kantarjian, Hagop; Arani, Naszrin; Popat, Uday; Bataller, Alex; Sasaki, Koji; DiNardo, Courtney D; Daver, Naval; Yilmaz, Musa; Abbas, Hussein A; Short, Nicholas J; Issa, Ghayas; Jabbour, Elias; Pierce, Sherry A; Chen, Julianne; Garcia, Ricky; Konopleva, Marina; Garcia-Manero, Guillermo; Alousi, Amin; Shpall, Elizabeth J; Champlin, Richard E; Borthakur, Gautam; Ravandi, Farhad; Kadia, Tapan.
Affiliation
  • Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Arani N; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Short NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chen J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Alousi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Borthakur G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 98(9): 1383-1393, 2023 09.
Article in En | MEDLINE | ID: mdl-37334870
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: United States